title: Simvastatin as a treatment for pulmonary hypertension trial.
abstract: BACKGROUND
  In animal models of pulmonary hypertension, simvastatin has been shown to reduce pulmonary artery pressure and induce regression of associated right ventricular (RV) hypertrophy.
  
  
  OBJECTIVE
  To assess the therapeutic value of simvastatin in patients with pulmonary arterial hypertension (PAH).
  
  
  METHODS
  Forty-two patients with PAH were randomized to receive either simvastatin (80 mg/d) or placebo in addition to current care for 6 months, and thereafter offered open-label simvastatin. The primary outcome was change in RV mass, assessed by cardiac magnetic resonance (CMR).
  
  
  RESULTS
  At 6 months, RV mass decreased by 5.2 +/- 11 g in the statin group (P = 0.045) and increased 3.9 +/- 14 g in the placebo group. The treatment effect was -9.1 g (P = 0.028). N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels decreased significantly in the statin group (-75 +/- 167 fmol/ml; P = 0.02) but not the placebo group (49 +/- 224 fmol/ml; P = 0.43; overall treatment effect -124 fmol/ml; P = 0.041). There were no significant changes in other outcome measures (including 6-minute walk test, cardiac index, and circulating cytokines). From 6 to 12 months, both RV mass and NT-proBNP increased toward baseline values in 16 patients on active treatment who continued with simvastatin but remained stable in 18 patients who switched from placebo to simvastatin. Two patients required a reduction in dose but not cessation of simvastatin.
  
  
  CONCLUSIONS
  Simvastatin added to conventional therapy produces a small and transient early reduction in RV mass and NT-proBNP levels in patients with PAH, but this is not sustained over 12 months.
authors.affiliation: Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, United Kingdom. m.wilkins@imperial.ac.uk
authors.forename: Martin R
authors.initials: MR
authors.lastname: Wilkins
authors.forename: Omar
authors.initials: O
authors.lastname: Ali
authors.forename: William
authors.initials: W
authors.lastname: Bradlow
authors.forename: John
authors.initials: J
authors.lastname: Wharton
authors.forename: Anne
authors.initials: A
authors.lastname: Taegtmeyer
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Rhodes
authors.forename: Hossein A
authors.initials: HA
authors.lastname: Ghofrani
authors.forename: Luke
authors.initials: L
authors.lastname: Howard
authors.forename: Petros
authors.initials: P
authors.lastname: Nihoyannopoulos
authors.forename: Raad H
authors.initials: RH
authors.lastname: Mohiaddin
authors.forename: J Simon R
authors.initials: JS
authors.lastname: Gibbs
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D017380:Hypertrophy, Right Ventricular / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood; D010446:Peptide Fragments / Q000097:blood; D019821:Simvastatin / Q000627:therapeutic use*; D014463:Ultrasonography; D055815:Young Adult
chemical_list: D000959:Antihypertensive Agents; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; D019821:Simvastatin
references.citation: Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H801-9
references.pmid: 18055512
references.citation: Eur Heart J. 2009 May;30(9):1057-65
references.pmid: 19168526
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2006 Dec;374(3):195-206
references.pmid: 17102939
references.citation: Trends Mol Med. 2008 Jan;14(1):37-44
references.pmid: 18068482
references.citation: Circulation. 2002 Dec 3;106(23):2913-8
references.pmid: 12460871
references.citation: Circulation. 2008 Mar 4;117(9):1238-43
references.pmid: 18316500
references.citation: Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H938-45
references.pmid: 12750068
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2006 Sep;373(6):401-14
references.pmid: 16896805
references.citation: Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2335-42
references.pmid: 16166567
references.citation: Eur Respir J. 2009 Dec;34(6):1219-63
references.pmid: 19749199
references.citation: Eur Heart J. 2007 May;28(10):1250-7
references.pmid: 17242010
references.citation: J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S97-S107
references.pmid: 19555863
references.citation: J Cardiovasc Magn Reson. 2005;7(4):705-16
references.pmid: 16136862
references.citation: Am J Respir Crit Care Med. 2008 Sep 1;178(5):534-41
references.pmid: 18565955
references.citation: Life Sci. 2008 May 7;82(19-20):991-6
references.pmid: 18400235
references.citation: J Biol Chem. 2005 Mar 18;280(11):10040-6
references.pmid: 15647265
references.citation: Cardiovasc Res. 2009 Jan 1;81(1):226-34
references.pmid: 18779230
references.citation: J Am Coll Cardiol. 1985 Apr;5(4):918-27
references.pmid: 3973294
references.citation: Ann Intern Med. 1991 Sep 1;115(5):343-9
references.pmid: 1863023
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 May;292(5):L1105-10
references.pmid: 17277047
references.citation: Am J Respir Crit Care Med. 2005 Jun 1;171(11):1292-7
references.pmid: 15750042
references.citation: Circulation. 2006 Oct 24;114(17):1883-91
references.pmid: 17060398
references.citation: J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S10-S19
references.pmid: 19555853
references.citation: Mol Cell Biochem. 2006 Mar;284(1-2):65-71
references.pmid: 16534557
references.citation: JAMA. 2004 Sep 15;292(11):1365-7
references.pmid: 15337731
references.citation: Circulation. 2009 Apr 28;119(16):2250-94
references.pmid: 19332472
references.citation: Circulation. 2003 Sep 30;108(13):1640-5
references.pmid: 12963647
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L630-8
references.pmid: 17575010
references.citation: Eur Respir J. 2009 Oct;34(4):948-57
references.pmid: 19797670
references.citation: Circulation. 1994 Apr;89(4):1733-44
references.pmid: 8149539
references.citation: Am J Physiol Lung Cell Mol Physiol. 2007 Oct;293(4):L933-40
references.pmid: 17675370
references.citation: Clin Pharmacokinet. 2003;42(3):293-301
references.pmid: 12603176
references.citation: Thorax. 2008 Mar;63 Suppl 2:ii1-ii41
references.pmid: 18308974
references.citation: Eur Heart J. 2006 Dec;27(23):2879-88
references.pmid: 17088316
references.citation: J Clin Invest. 2001 Nov;108(10):1429-37
references.pmid: 11714734
references.citation: Am J Respir Crit Care Med. 2002 Nov 15;166(10):1403-8
references.pmid: 12406854
references.citation: J Pharm Pharm Sci. 2009 Feb 04;11(2):118s-130s
references.pmid: 19203474
references.citation: Chest. 2005 Apr;127(4):1446-52
references.pmid: 15821229
references.citation: Clin Chem. 2007 Feb;53(2):284-91
references.pmid: 17185363
references.citation: J Am Soc Echocardiogr. 1996 Nov-Dec;9(6):838-47
references.pmid: 8943444